Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence D True

Showing results (161-170 of 204) with videos related to

Pageof 21
Sort By:
Nature Medicine|March 2, 2016
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancerAkash Kumar, Ilsa Coleman, Colm Morrissey, et al.
Cancer Research|December 2, 2021
Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning-Assisted Gland AnalysisWeisi Xie, Nicholas P Reder, Can Koyuncu, et al.
Nature Communications|April 11, 2023
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapyVipul Bhatia, Nikhil V Kamat, Tiffany E Pariva, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2016
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISHTamara L Lotan, Wei Wei, Olga Ludkovski, et al.
The Prostate|June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy CohortJames D Brooks, Wei Wei, Jonathan R Pollack, et al.
Scientific Reports|January 4, 2024
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarkerShiqin Liu, Sarah J Hawley, Christian A Kunder, et al.
The American Journal of Surgical Pathology|September 17, 2016
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective CohortJesse K McKenney, Wei Wei, Sarah Hawley, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Deep-learning triage of 3D pathology datasets for comprehensive and efficient pathologist assessmentsGan Gao, Renao Yan, Andrew H Song, et al.
The Journal of Clinical Investigation|July 31, 2019
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancerMark P Labrecque, Ilsa M Coleman, Lisha G Brown, et al.
Clinical Genitourinary Cancer|November 8, 2020
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) ProgramLeonidas N Diamantopoulos, Sarah K Holt, Ali R Khaki, et al.
Pageof 21

Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Nature Medicine|March 2, 2016
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancerAkash Kumar, Ilsa Coleman, Colm Morrissey, et al.
Cancer Research|December 2, 2021
Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning-Assisted Gland AnalysisWeisi Xie, Nicholas P Reder, Can Koyuncu, et al.
Nature Communications|April 11, 2023
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapyVipul Bhatia, Nikhil V Kamat, Tiffany E Pariva, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2016
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISHTamara L Lotan, Wei Wei, Olga Ludkovski, et al.
The Prostate|June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy CohortJames D Brooks, Wei Wei, Jonathan R Pollack, et al.
Scientific Reports|January 4, 2024
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarkerShiqin Liu, Sarah J Hawley, Christian A Kunder, et al.
The American Journal of Surgical Pathology|September 17, 2016
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective CohortJesse K McKenney, Wei Wei, Sarah Hawley, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Deep-learning triage of 3D pathology datasets for comprehensive and efficient pathologist assessmentsGan Gao, Renao Yan, Andrew H Song, et al.
The Journal of Clinical Investigation|July 31, 2019
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancerMark P Labrecque, Ilsa M Coleman, Lisha G Brown, et al.
Clinical Genitourinary Cancer|November 8, 2020
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) ProgramLeonidas N Diamantopoulos, Sarah K Holt, Ali R Khaki, et al.
Pageof 21